Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2326 AL 2340

Modulating macroautophagy: a neuronal perspective

Johnson CW, Melia TJ, Yamamoto A.

Future Med Chem. 2012 Sep;4(13):1715-31. doi: 10.4155/fmc.12.112.

ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia

Brashear A, Mink JW, Hill DF, Boggs N, McCall WV, Stacy MA, Snively B, Light LS, Sweadner KJ, Ozelius LJ, Morrison L.

Dev Med Child Neurol. 2012 Nov;54(11):1065-7. doi: 10.1111/j.1469-8749.2012.04421.x. Epub 2012 Aug 28.

[Apathy in Parkinson's disease: clinical features, mechanisms and assessment]

Dujardin K, Defebvre L.

Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):598-604. doi: 10.1016/j.neurol.2012.05.002. Epub 2012 Aug 24.

Parkinsonism in elderly users of haloperidol: associated with dose, plasma concentration, and duration of use

Knol W, van Marum RJ, Jansen PA, Egberts TC, Schobben AF.

J Clin Psychopharmacol. 2012 Oct;32(5):688-93. doi: 10.1097/JCP.0b013e318268e0d2.

Sham surgery controls in Parkinson's disease clinical trials: views of participants

Kim SY, De Vries R, Holloway RG, Wilson R, Parnami S, Kim HM, Frank S, Kieburtz K.

Mov Disord. 2012 Sep 15;27(11):1461-5. doi: 10.1002/mds.25155. Epub 2012 Aug 23.

Lysosome-dependent pathways as a unifying theme in Parkinson's disease

Tofaris GK.

Mov Disord. 2012 Sep 15;27(11):1364-9. doi: 10.1002/mds.25136. Epub 2012 Aug 23.

[Analysis of sustained attention in patients with Parkinson's disease being treated with dopamine precursors]

Luque-Moreno C, López-García JC, Díaz-Argandoña E.

Rev Neurol. 2012 Sep 1;55(5):257-62.

[New therapeutic approaches in the treatment of neglect: transcranial magnetic stimulation]

Muñoz-Marrón E, Redolar-Ripoll D, Zulaica-Cardoso A.

Rev Neurol. 2012 Sep 1;55(5):297-305.

The subthalamic nucleus at 7.0 Tesla: evaluation of sequence and orientation for deep-brain stimulation

Kerl HU, Gerigk L, Pechlivanis I, Al-Zghloul M, Groden C, Nölte IS.

Acta Neurochir (Wien). 2012 Nov;154(11):2051-62. doi: 10.1007/s00701-012-1476-0. Epub 2012 Aug 29.

Vitamin D and Parkinson's disease

Vinh Quôc Luong K, Thi Hoàng Nguyên L.

J Neurosci Res. 2012 Dec;90(12):2227-36. doi: 10.1002/jnr.23115. Epub 2012 Aug 28.

Atypical motor and behavioral presentations of Alzheimer disease: a case-based approach

Duker AP, Espay AJ, Wszolek ZK, Rademakers R, Dickson DW, Kelley BJ.

Neurologist. 2012 Sep;18(5):266-72. doi: 10.1097/NRL.0b013e3182675376.

[Camptocormia in the differential diagnosis of hyperkyphosis and ankylosing spondylitis]

Sarholz M, Vorgerd M, Braun J.

Dtsch Med Wochenschr. 2012 Sep;137(36):1736-9. doi: 10.1055/s-0032-1305212. Epub 2012 Aug 29.

Role of formyl peptide receptors (FPR) in abnormal inflammation responses involved in neurodegenerative diseases

Mollica A, Stefanucci A, Costante R, Pinnen F.

Antiinflamm Antiallergy Agents Med Chem. 2012;11(1):20-36. doi: 10.2174/187152312803476246.

Effects of magnitude and magnitude predictability of postural perturbations on preparatory cortical activity in older adults with and without Parkinson's disease

Smith BA, Jacobs JV, Horak FB.

Exp Brain Res. 2012 Oct;222(4):455-70. doi: 10.1007/s00221-012-3232-3. Epub 2012 Aug 31.

Mitochondrial fission, fusion, and stress

Youle RJ, van der Bliek AM.

Science. 2012 Aug 31;337(6098):1062-5. doi: 10.1126/science.1219855.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias